Fasenra 30 mg Injection 1 ml

Fasenra 30 mg Injection 1 ml belongs to the class of 'immunomodulators', primarily used to treat asthma. Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing. Fasenra 30 mg Injection 1 ml is used as an add-on maintenance treatment in severe asthma patients above 12 years of age.

Fasenra 30 mg Injection 1 ml consists of Benralizumab as an active ingredient which belongs to interleukin-5 receptor (IgG1) monoclonal antibody (that serves as a substitute antibody). It works by reducing the synthesis of cytokine, a substance released by the body that initiates an inflammatory response.

Fasenra 30 mg Injection 1 ml may cause common side effects such as fever, itching, headache, sore throat, and breathing difficulty. These side effects resolve over time. Inform your doctor if any of these side effects bother you. Fasenra 30 mg Injection 1 ml will be administered by a healthcare professional. Do not self-administer.

Fasenra 30 mg Injection 1 ml should be avoided if allergic to it or any other components present in it. Before starting Fasenra 30 mg Injection 1 ml, inform your doctor if you have any liver or kidney disease or active parasitic infections and are taking any inhaled corticosteroids. Pregnant and breastfeeding mothers should inform the physician before starting treatment with Fasenra 30 mg Injection 1 ml. Fasenra 30 mg Injection 1 ml may cause dizziness, so drive only if you are alert and focused. Avoid consuming alcohol along with Fasenra 30 mg Injection 1 ml as it could lead to increased dizziness.

Fasenra 30 mg Injection 1 ml is used in the treatment of Asthma. The detailed uses of Fasenra 30 mg Injection 1 ml are as follows:

• Treatment of Asthma: Fasenra 30 mg Injection 1 ml is used in the maintenance treatment of severe eosinophilic asthma and helps with reduction in asthma exacerbations (severe flare-ups).
• Improve lung function: Fasenra 30 mg Injection 1 ml helps in the improvement in lung function and breathing capacity.
• Treatment of eosinophilic granulomatosis with polyangiitis (EGPA): Fasenra 30 mg Injection 1 ml is used in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) a rare autoimmune condition.

• Follow your doctor's recommendations for the correct dosage and timing of this medication.
• Check the label for directions and use it as advised by the doctor. Choose an injection site such as the thigh, upper arm, or abdomen; pinch the skin and inject the advised dose slowly and steadily.
• Rotate the injection site each time.
• Do not inject into skin that is red, bruised, or hard.

Fasenra 30 mg Injection 1 ml contains Benralizumab, which is a humanized recombinant IgG1 (Immunoglobulin G1) monoclonal antibody. It works by binding to the IgG1 receptor and reduces the synthesis of cytokine, a substance released by the body that initiates an inflammatory response. Fasenra 30 mg Injection 1 ml is used as a maintenance treatment in asthma patients.

To treat your condition effectually, continue taking Fasenra 30 mg Injection 1 ml for the period that your doctor has prescribed. Avoid taking Fasenra 30 mg Injection 1 ml if you are allergic to it or any other components present in it. Inform your doctor if you have any liver or kidney diseases, active parasitic infections, and are taking any inhaled corticosteroids before receiving Fasenra 30 mg Injection 1 ml. Avoid close contact with people who have infections that can be easily spread. Fasenra 30 mg Injection 1 ml may cause dizziness, so drive only if you are alert and focused. Avoid consuming alcohol along with Fasenra 30 mg Injection 1 ml as it could lead to increased dizziness. Fasenra 30 mg Injection 1 ml is not recommended in children below 12 years of age as safety and efficacy are not established. Fasenra 30 mg Injection 1 ml may cause severe allergic reactions and parasitic reactions and reduce the effect of corticosteroid medicines. Hence, inform your doctor about your complete medication and medical history before taking Fasenra 30 mg Injection 1 ml.